Search

everythinglearnresearchcommunity

for

Search:↓

Combination therapy with cyclosporine and low-dose corticosteroid shows favorable long-term results for treating alopecia areata.

A new type of rapid hair loss called ADTA usually gets better on its own within 6 months.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Dilated follicular infundibula and increased catagen/telogen follicles are key indicators for diagnosing alopecia areata.

The study concluded that severity of Frontal fibrosing alopecia is not linked to how long someone has it, can start before menopause, and eyebrow loss may be an early sign.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

Hyaluronic acid injections can cause hair loss due to blocked blood vessels.

CD80CD86 deficiency causes hair loss by disrupting regulatory T cells.

A woman with complete hair loss and severe hyperthyroidism was successfully treated with azathioprine and hydroxychloroquine.

Platelet rich plasma is an effective treatment for alopecia areata.

People with alopecia areata had lower vitamin D levels, but these levels didn't relate to many aspects of the condition.

Ayurvedic treatments helped a 16-year-old regrow hair after modern medicine failed.

Adding PRP to topical mometasone improves and speeds up alopecia areata treatment.

Trichoscopy can reliably distinguish between alopecia areata and trichotillomania.

Japanese patients and physicians often disagree on the severity of Alopecia Areata and treatment satisfaction, needing better communication and treatments.

Ayurvedic treatment successfully regrew hair in a 7-year-old girl with alopecia areata.

A teenager had both alopecia areata and vitiligo, which are rare to occur together.

A man had both alopecia areata and lichen planus, which is uncommon.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

FFA's causes may include environmental triggers and genetic factors.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Platelet-rich plasma (PRP) is a safe and potentially effective way to treat hair loss, especially when combined with minoxidil.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

People with alopecia areata have higher rates of mental health issues, autoimmune diseases, and infections.

Malondialdehyde-modified DNA may trigger an immune response in alopecia areata patients.

People with certain types of alopecia have a slightly higher risk of cancer, especially thyroid, bladder, and prostate cancers.

Six African American women experienced hair loss after switching to a new HIV medication.